Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Vesugen cycle length: what human studies ran

Not approved — research use onlyCPreclinical research
Short answer: there is no established Vesugen cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Vesugen combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Vesugen cycle length?
No. We found no human studies that report a treatment duration for Vesugen.
What is the longest human study of Vesugen?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Vesugen dosing reference Full research page

References

  1. [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging] Adv Gerontol. 2014
  2. [The efficacy of peptide bioregulators of vessels in lower limbs chronic arterial insufficiency treatment in old and elderly people] Adv Gerontol. 2014
  3. Short peptides stimulate serotonin expression in cells of brain cortex Bull Exp Biol Med. 2014
  4. [Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis] Adv Gerontol. 2016
  5. Peptides tissue-specifically stimulate cell differentiation during their aging Bull Exp Biol Med. 2012
  6. Drugs@FDA: FDA-Approved Drugs (search of approved applications) FDA Drugs@FDA / openFDA drug/drugsfda. 2026
  7. DailyMed label search (structured product labels) NLM DailyMed. 2026
  8. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the FD&C Act, updated May 14, 2026 FDA. 2026
  9. World Anti-Doping Code International Standard: Prohibited List 2026 WADA. 2026
  10. Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture Bull Exp Biol Med. 2011
  11. [The role of vasoactive peptid in lower limbs chronic arterial insufficiency treatment] Adv Gerontol. 2013
  12. [TREATMENT OF CHEMICAL STOMATITIS IN PEOPLE OF ADVANCED AND SENILE AGE] Adv Gerontol. 2013
  13. [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION] Adv Gerontol. 2015
  14. [Comparative analysis of different methods of geroprotective] Adv Gerontol. 2016